AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33001314 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin antimicrobial stewardship intervention
Number of subjects: 9
Study 35906623 — intervention group
Group type: EXPERIMENTAL
Intervention: 61.2 Gy radiation dose with concurrent chemoradiotherapy (paclitaxel/cisplatin regimen for 2 cycles followed by consolidation chemotherapy for 2 cycles)
Number of subjects: 646
Study 35906623 — intervention group
Group type: COMPARATOR
Intervention: 50.4 Gy radiation dose with concurrent chemoradiotherapy (paclitaxel/cisplatin regimen for 2 cycles followed by consolidation chemotherapy for 2 cycles)
Number of subjects: 646
Study 34600308 — intervention group
Group type: EXPERIMENTAL
Intervention: Mantra meditation
Number of subjects: 31
Study 34600308 — intervention group
Group type: COMPARATOR
Intervention: Classical music listening
Number of subjects: 31
Study 32246153 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaced formats of Prolonged Exposure (PE) or Present Centered Therapy
Number of subjects: 128
Study 32246153 — intervention group
Group type: EXPERIMENTAL
Intervention: Massed format of Prolonged Exposure (PE)
Number of subjects: 128
Study 32246153 — intervention group
Group type: COMPARATOR
Intervention: Baseline sleep disorder symptoms
Number of subjects: 128
Study 32246153 — intervention group
Group type: COMPARATOR
Intervention: Short weekends/off days sleep
Number of subjects: 128
Study 33896213 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained natural apophyseal glides
Number of subjects: 80
Study 33896213 — intervention group
Group type: COMPARATOR
Intervention: Detuned laser (placebo)
Number of subjects: 80
Study 37164603 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 232
Study 37164603 — intervention group
Group type: COMPARATOR
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 232
Study 33726777 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Early Learning (AEL) program
Number of subjects: 314
Study 33726777 — intervention group
Group type: COMPARATOR
Intervention: Usual practice care (control)
Number of subjects: 314
Study 32667286 — intervention group
Group type: EXPERIMENTAL
Intervention: Selgantolimod 0.5 mg
Number of subjects: 71
Study 32667286 — intervention group
Group type: EXPERIMENTAL
Intervention: Selgantolimod 1.5 mg
Number of subjects: 71
Study 32667286 — intervention group
Group type: EXPERIMENTAL
Intervention: Selgantolimod 3 mg
Number of subjects: 71
Study 32667286 — intervention group
Group type: EXPERIMENTAL
Intervention: Selgantolimod 5 mg
Number of subjects: 71
Study 32667286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 32667286 — intervention group
Group type: EXPERIMENTAL
Intervention: Food effect
Number of subjects: 71
Study 35333492 — intervention group
Group type: EXPERIMENTAL
Intervention: Tislelizumab plus platinum-pemetrexed (arm T + PP)
Number of subjects: 332
Study 35333492 — intervention group
Group type: COMPARATOR
Intervention: Platinum-pemetrexed alone (arm PP)
Number of subjects: 332
Study 32444058 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion for 10 minutes every night for 2 weeks
Number of subjects: 80
Study 32444058 — intervention group
Group type: COMPARATOR
Intervention: Warm water immersion for 10 minutes every night for 2 weeks
Number of subjects: 80
Study 32444058 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (cold and warm water)
Number of subjects: 80
Study 35302551 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing Technique (ACBT)
Number of subjects: 34
Study 35302551 — intervention group
Group type: COMPARATOR
Intervention: Usual pre‐/postoperative breathing exercises
Number of subjects: 34
Study 33319493 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-ablation (CA)
Number of subjects: 81
Study 33319493 — intervention group
Group type: COMPARATOR
Intervention: Argon-helium cryoablation (AHC)
Number of subjects: 81
Study 35549980 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided digital therapeutic application with exposure-based behavioral experiments in VR
Number of subjects: 40
Study 35549980 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 40
Study 34291626 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary physical interventions (balance training, resistance training, cycling ergometer) in addition to standard cardiac rehabilitation (CR)
Number of subjects: 75
Study 34291626 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary physical interventions
Number of subjects: 75
Study 34291626 — intervention group
Group type: COMPARATOR
Intervention: Standard cardiac rehabilitation (CR)
Number of subjects: 75
Study 32894117 — intervention group
Group type: EXPERIMENTAL
Intervention: Contracted endodontic cavity (CEC)
Number of subjects: 40
Study 32894117 — intervention group
Group type: COMPARATOR
Intervention: Traditional endodontic cavity (TEC)
Number of subjects: 40
Study 34419232 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging interventions (4 different types with varying personalization, interactivity, and message frequency)
Number of subjects: 277
Study 33202893 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening exercise protocol for 9 weeks (two sessions of 40 min per week)
Number of subjects: 36
Study 33202893 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 36
Study 33865648 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsulotomy
Number of subjects: 98
Study 33865648 — intervention group
Group type: COMPARATOR
Intervention: Capsulectomy
Number of subjects: 98
Study 32282015 — intervention group
Group type: EXPERIMENTAL
Intervention: PASTA intervention
Number of subjects: 1214
Study 32282015 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1214
Study 35149904 — intervention group
Group type: EXPERIMENTAL
Intervention: ZipBond X (ZBX) in self-etch mode (ZBX-SE)
Number of subjects: 64
Study 35149904 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime and Bond Active (PBA) in self-etch mode (PBA-SE)
Number of subjects: 64
Study 35149904 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (SCH) in self-etch mode (SCH-SE)
Number of subjects: 64
Study 35149904 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick (CQB) in self-etch mode (CQB-SE)
Number of subjects: 64
Study 35149904 — intervention group
Group type: EXPERIMENTAL
Intervention: ZipBond X (ZBX) in etch-and-rinse mode (ZBX-ER)
Number of subjects: 64
Study 35149904 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (SCH) in etch-and-rinse mode (SCH-ER)
Number of subjects: 64
Study 35149904 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime and Bond Active (PBA) in etch-and-rinse mode (PBA-ER)
Number of subjects: 64
Study 35149904 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick (CQB) in etch-and-rinse mode (CQB-ER)
Number of subjects: 64
Study 34776125 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Tape application on ankle (G1)
Number of subjects: 48
Study 34776125 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Tape application on hamstrings (G2)
Number of subjects: 48
Study 33407298 — intervention group
Group type: EXPERIMENTAL
Intervention: Male friendly clinic offering private, quick, supportive/sensitive and flexible service
Number of subjects: 62
Study 33407298 — intervention group
Group type: EXPERIMENTAL
Intervention: Compensation to cover transport and opportunity cost for attending the clinic
Number of subjects: 62
Study 33407298 — intervention group
Group type: COMPARATOR
Intervention: Peer pressure and fear of being seen at ANC
Number of subjects: 62
Study 33407298 — intervention group
Group type: COMPARATOR
Intervention: Health system problems associated with ANC services organization
Number of subjects: 62
Study 33407298 — intervention group
Group type: COMPARATOR
Intervention: Association between ANC and HIV testing services
Number of subjects: 62
Study 35871420 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative Expressive Arts‐based Storytelling (CrEAS)
Number of subjects: 135
Study 33169345 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 1000 mg
Number of subjects: 14
Study 33169345 — intervention group
Group type: COMPARATOR
Intervention: Normal hepatic function (Control)
Number of subjects: 14
Study 32845584 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1614
Study 35380672 — intervention group
Group type: EXPERIMENTAL
Intervention: Real bilateral tDCS (anodal right/cathodal left)
Number of subjects: 42
Study 35380672 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 42
Study 34598981 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based complex intervention on relapse management
Number of subjects: 188
Study 32275365 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at governor vessel combined with donepezil hydrochloride (5 mg/day, increased to 10 mg/day after 4 weeks if needed) for 8 weeks.
Number of subjects: 60
Study 32275365 — intervention group
Group type: COMPARATOR
Intervention: Donepezil hydrochloride alone (5 mg/day, increased to 10 mg/day after 4 weeks if needed) for 8 weeks.
Number of subjects: 60
Study 34043898 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based cognitive-behavioral intervention (nine 15-20 minute sessions, three days a week for three weeks)
Number of subjects: 150
Study 34043898 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based cognitive-behavioral intervention
Number of subjects: 150
Study 34043898 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 150
Study 32428549 — intervention group
Group type: EXPERIMENTAL
Intervention: DRN-DCMB model
Number of subjects: 207
Study 35365412 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP flap
Number of subjects: 50
Study 35365412 — intervention group
Group type: COMPARATOR
Intervention: LD flap
Number of subjects: 50
Study 33857327 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/d
Number of subjects: 308
Study 33857327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 32222857 — intervention group
Group type: EXPERIMENTAL
Intervention: SBM25
Number of subjects: 200
Study 32222857 — intervention group
Group type: EXPERIMENTAL
Intervention: SBM50
Number of subjects: 200
Study 32222857 — intervention group
Group type: EXPERIMENTAL
Intervention: SBM75
Number of subjects: 200
Study 32222857 — intervention group
Group type: COMPARATOR
Intervention: SBM0
Number of subjects: 200
Study 32222857 — intervention group
Group type: EXPERIMENTAL
Intervention: SBM100
Number of subjects: 200
Study 35786578 — intervention group
Group type: EXPERIMENTAL
Intervention: XP Finisher
Number of subjects: 75
Study 35786578 — intervention group
Group type: EXPERIMENTAL
Intervention: XP Finisher R
Number of subjects: 75
Study 35786578 — intervention group
Group type: COMPARATOR
Intervention: Passive Ultrasonic Irrigation
Number of subjects: 75
Study 35470860 — intervention group
Group type: EXPERIMENTAL
Intervention: Quit Genius (digital clinician‐assisted CBT intervention)
Number of subjects: 556
Study 35470860 — intervention group
Group type: COMPARATOR
Intervention: Very Brief Advice (VBA)
Number of subjects: 556
Study 35470860 — intervention group
Group type: EXPERIMENTAL
Intervention: Quit Genius
Number of subjects: 556
Study 34580704 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital delay to surgery of less than 8 hours
Number of subjects: 1800
Study 34580704 — intervention group
Group type: COMPARATOR
Intervention: In-hospital delay to surgery of less than 24 hours
Number of subjects: 1800
Study 34580704 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics while waiting for surgery
Number of subjects: 1800
Study 34580704 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics while waiting for surgery
Number of subjects: 1800
Study 34580704 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of hospital stay
Number of subjects: 1800
Study 34580704 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-day complications graded using Clavien-Dindo classification
Number of subjects: 1800
Study 34580704 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pain
Number of subjects: 1800
Study 34580704 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversion rate
Number of subjects: 1800
Study 34580704 — intervention group
Group type: EXPERIMENTAL
Intervention: Histopathological diagnosis
Number of subjects: 1800
Study 34580704 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunshine Appendicitis Grading System classification
Number of subjects: 1800
Study 35645167 — intervention group
Group type: EXPERIMENTAL
Intervention: as-needed budesonide-formoterol (BFM) (160/4.5 μg)
Number of subjects: 31
Study 35645167 — intervention group
Group type: COMPARATOR
Intervention: budesonide (BUD) (200 μg) twice daily
Number of subjects: 31
Study 35645167 — intervention group
Group type: EXPERIMENTAL
Intervention: as-needed budesonide-formoterol (BFM)
Number of subjects: 31
Study 35645167 — intervention group
Group type: COMPARATOR
Intervention: budesonide (BUD)
Number of subjects: 31
Study 32590084 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood transfusion
Number of subjects: 12547
Study 34894712 — intervention group
Group type: EXPERIMENTAL
Intervention: Using less thickener (pudding vs nectar)
Number of subjects: 202
Study 34894712 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet types (pureed, soft, mixed, regular)
Number of subjects: 202
Study 34894712 — intervention group
Group type: COMPARATOR
Intervention: Home vs Nursing Home residence
Number of subjects: 202
Study 34894712 — intervention group
Group type: COMPARATOR
Intervention: Fears (Home vs Nursing Home)
Number of subjects: 202
Study 34894712 — intervention group
Group type: COMPARATOR
Intervention: Mental health (Home vs Nursing Home)
Number of subjects: 202
Study 34894712 — intervention group
Group type: COMPARATOR
Intervention: Food selection (Home vs Nursing Home)
Number of subjects: 202
Study 35987543 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive bias modification, interpretation retraining (CBM‐I)
Number of subjects: 167
Study 35987543 — intervention group
Group type: COMPARATOR
Intervention: Guided visualization relaxation training
Number of subjects: 167
Study 32044165 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation to PTVelect up to EQD2 of 40 Gy
Number of subjects: 200
Study 32044165 — intervention group
Group type: COMPARATOR
Intervention: Irradiation to PTVelect up to EQD2 of 50 Gy
Number of subjects: 200
Study 35082352 — intervention group
Group type: EXPERIMENTAL
Intervention: MF-myofascial release
Number of subjects: 60
Study 35082352 — intervention group
Group type: EXPERIMENTAL
Intervention: E-exercise program
Number of subjects: 60
Study 35082352 — intervention group
Group type: EXPERIMENTAL
Intervention: MFE-myofascial release and exercise program
Number of subjects: 60
Study 35082352 — intervention group
Group type: COMPARATOR
Intervention: C-no intervention
Number of subjects: 60
Study 33902160 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest CT findings
Number of subjects: 89
Study 35731318 — intervention group
Group type: EXPERIMENTAL
Intervention: Open access (OA) program
Number of subjects: 120
Study 35731318 — intervention group
Group type: COMPARATOR
Intervention: RCT program
Number of subjects: 120
Study 34333388 — intervention group
Group type: EXPERIMENTAL
Intervention: Algae ingredient (0.175%) in diet during Eimeria challenge
Number of subjects: 1200
Study 34333388 — intervention group
Group type: EXPERIMENTAL
Intervention: Algae ingredient (0.175%) in diet, unchallenged
Number of subjects: 1200
Study 34333388 — intervention group
Group type: COMPARATOR
Intervention: Control diet (no algae ingredient)
Number of subjects: 1200
Study 32079739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided rhomboid intercostal block with 30 mL 0.25% bupivacaine
Number of subjects: 0
Study 32079739 — intervention group
Group type: COMPARATOR
Intervention: Control group (no block intervention)
Number of subjects: 0
Study 36328447 — intervention group
Group type: EXPERIMENTAL
Intervention: Melinjo seed extract
Number of subjects: 0
Study 36328447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33478482 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin extract (Curcugen™) 500 mg once daily for 8 weeks
Number of subjects: 79
Study 33478482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 36151976 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort‐in™ injection system (CIS)
Number of subjects: 48
Study 36151976 — intervention group
Group type: COMPARATOR
Intervention: Traditional anesthesia (TA)
Number of subjects: 48
Study 33586796 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle-sparing lateral thoracotomy (MSLT)
Number of subjects: 28
Study 33586796 — intervention group
Group type: COMPARATOR
Intervention: Standard lateral thoracotomy (SLT)
Number of subjects: 28
Study 33586796 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MSLT and SLT
Number of subjects: 28
Study 34470496 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 30
Study 34470496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33245858 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (100 mg oral for 5 days, tapering 20 mg every 3 days for a total of 17 days)
Number of subjects: 116
Study 33245858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 36114520 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy
Number of subjects: 0
Study 36114520 — intervention group
Group type: COMPARATOR
Intervention: Social Skills Training
Number of subjects: 0
Study 33538638 — intervention group
Group type: EXPERIMENTAL
Intervention: Bremelanotide
Number of subjects: 250
Study 33538638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 32776664 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT) for AIS
Number of subjects: 166
Study 36216430 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 160
Study 36216430 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 160
Study 36216430 — intervention group
Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 160
Study 32086272 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 100 mg daily
Number of subjects: 20
Study 32086272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32424376 — intervention group
Group type: EXPERIMENTAL
Intervention: Method A (presoaking in 1% sodium dodecyl sulfate followed by ultrasonication with 4 mol/L guanidine hydrochloride)
Number of subjects: 40
Study 32424376 — intervention group
Group type: COMPARATOR
Intervention: Method B (soaking in distilled water followed by ultrasonication with 4 mol/L guanidine hydrochloride)
Number of subjects: 40
Study 36127097 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal CT scanning following thoracic low-dose CT (LDCT) for lung cancer screening
Number of subjects: 4700
Study 36127097 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 4700
Study 32570654 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Prescription systems
Number of subjects: 157
Study 35019886 — intervention group
Group type: EXPERIMENTAL
Intervention: N‐ESAR foot prosthesis
Number of subjects: 20
Study 35019886 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid‐ankle cushioned‐heel prosthesis
Number of subjects: 20
Study 34047299 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue (Glubran 2)
Number of subjects: 106
Study 34047299 — intervention group
Group type: COMPARATOR
Intervention: Absorbable tacks
Number of subjects: 106
Study 35733183 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer videorecording feedback training (PVF)
Number of subjects: 127
Study 35733183 — intervention group
Group type: COMPARATOR
Intervention: Traditional peer verbal feedback training (TVF)
Number of subjects: 127
Study 34467834 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol 1000 mg daily for 3 months
Number of subjects: 41
Study 34467834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 35302628 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric assessment (GA) summary with recommendations provided to oncologists prior to clinical encounter.
Number of subjects: 541
Study 35921122 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodal observation with ultrasonography
Number of subjects: 823
Study 35421451 — intervention group
Group type: EXPERIMENTAL
Intervention: Aperiodic sensory stimulation
Number of subjects: 0
Study 35421451 — intervention group
Group type: COMPARATOR
Intervention: Periodic sensory stimulation
Number of subjects: 0
Study 35857241 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics (1 g containing both pre- and probiotics administered twice a day for 14 days)
Number of subjects: 86
Study 35857241 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar-looking to synbiotics)
Number of subjects: 86
Study 35857241 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics
Number of subjects: 86
Study 35857241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 32928070 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA plus compression (RF)
Number of subjects: 56
Study 32928070 — intervention group
Group type: COMPARATOR
Intervention: Compression alone (CR)
Number of subjects: 56
Study 32619715 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) using methylene blue mediated gallium aluminum arsenide laser at 635 nm, 6.5 J/cm2 for 10 seconds at 10 points, applied immediately after first wire and at days 3, 7, 14 of the first month, repeated for additional 2 months.
Number of subjects: 30
Study 32619715 — intervention group
Group type: COMPARATOR
Intervention: Control group without PDT intervention.
Number of subjects: 30
Study 36126327 — intervention group
Group type: EXPERIMENTAL
Intervention: STRT+Leu (16 g of protein containing ∼3 g of leucine)
Number of subjects: 8
Study 36126327 — intervention group
Group type: COMPARATOR
Intervention: STRT
Number of subjects: 8
Study 36126327 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 8
Study 36126327 — intervention group
Group type: EXPERIMENTAL
Intervention: STRT+Leu
Number of subjects: 8
Study 32324711 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery (ERAS) protocols
Number of subjects: 0
Study 32324711 — intervention group
Group type: EXPERIMENTAL
Intervention: Modifications to typical ERAS protocols
Number of subjects: 0